180 related articles for article (PubMed ID: 38137623)
1. Rate of Leiomyosarcomas during Surgery for Uterine Fibroids: 8-Year Experience of a Single Center.
Zouzoulas D; Tsolakidis D; Pavlidi OI; Pappas PD; Theodoridis T; Pados G; Pervana S; Pazarli E; Grimbizis G
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137623
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of occult leiomyosarcomas and atypical leiomyomas after laparoscopic morcellation of leiomyomas in reproductive-age women.
Pados G; Tsolakidis D; Theodoulidis V; Makedos A; Zaramboukas T; Tarlatzis B
Hum Reprod; 2017 Oct; 32(10):2036-2041. PubMed ID: 28938732
[TBL] [Abstract][Full Text] [Related]
3. Risk of morcellation of uterine leiomyosarcomas in laparoscopic supracervical hysterectomy and laparoscopic myomectomy, a retrospective trial including 4791 women.
Lieng M; Berner E; Busund B
J Minim Invasive Gynecol; 2015; 22(3):410-4. PubMed ID: 25460521
[TBL] [Abstract][Full Text] [Related]
4. A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma.
Wais M; Tepperman E; Bernardini MQ; Gien LT; Jimenez W; Murji A
J Obstet Gynaecol Can; 2017 Aug; 39(8):652-658. PubMed ID: 28729098
[TBL] [Abstract][Full Text] [Related]
5. Occult Leiomyosarcomas in a Canadian Province: A Retrospective Cohort Study.
Wu CQ; Woo LY; Giede KC; Thiel J; Karreman E; Rattray DD
J Obstet Gynaecol Can; 2019 Jan; 41(1):46-51. PubMed ID: 30341020
[TBL] [Abstract][Full Text] [Related]
6. Risk of unexpected uterine leiomyosarcoma during laparoscopic procedures: Experience from a single tertiary institute in Italy.
Surace A; Baù MG; Privitera S; Botta G; Danese S; Plazzotta C; Mitidieri M; Picardo E
Int J Gynaecol Obstet; 2022 Feb; 156(2):236-239. PubMed ID: 33834486
[TBL] [Abstract][Full Text] [Related]
7. Uterine leiomyosarcoma - incidence, treatment, and the impact of morcellation. A nationwide cohort study.
Skorstad M; Kent A; Lieng M
Acta Obstet Gynecol Scand; 2016 Sep; 95(9):984-90. PubMed ID: 27223683
[TBL] [Abstract][Full Text] [Related]
8. Unexpected uterine sarcomas after hysterectomy and myomectomy for presumed leiomyoma: a retrospective study of 26,643 patients.
Cao H; Li L; Yang B; Luo G; Lou J; Xi M
Cancer Manag Res; 2019; 11():7007-7014. PubMed ID: 31440089
[TBL] [Abstract][Full Text] [Related]
9. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
10. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas.
Chen Q; Shi H; Lu W; Lu B
Eur J Obstet Gynecol Reprod Biol; 2018 Nov; 230():85-89. PubMed ID: 30245442
[TBL] [Abstract][Full Text] [Related]
11. In-bag manual versus uncontained power morcellation for laparoscopic myomectomy.
Zullo F; Venturella R; Raffone A; Saccone G
Cochrane Database Syst Rev; 2020 May; 5(5):CD013352. PubMed ID: 32374421
[TBL] [Abstract][Full Text] [Related]
12. Does fibroids surgery by endoscopy or laparotomy represent a malignancy threat?
Mettler L; Abdusattarova K; Alkatout I
Minerva Ginecol; 2017 Dec; 69(6):517-525. PubMed ID: 28696085
[TBL] [Abstract][Full Text] [Related]
13. Frequency of uterine sarcomas in patients admitted for uterine fibroid surgery.
Mettler L; Maass N; Abdusattarova K; Dempfle A; Alkatout I
J Turk Ger Gynecol Assoc; 2017 Jun; 18(2):62-66. PubMed ID: 28400352
[TBL] [Abstract][Full Text] [Related]
14. Incidence of occult uterine sarcoma and other unexpected pathologies in patients having surgery for presumed myomas: A retrospective observational study.
Mühlenbrock MV; Navarrete-Rey P; Kovoor E; Guzman-Rojas R; Troncoso F; Miranda-Mendoza I
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):101992. PubMed ID: 33217603
[TBL] [Abstract][Full Text] [Related]
15. Incidence of Tissue Morcellation During Surgery for Uterine Sarcoma at a Canadian Academic Centre.
Chen I; Hopkins L; Firth B; Boucher J; Singh SS
J Obstet Gynaecol Can; 2015 May; 37(5):421-425. PubMed ID: 26168102
[TBL] [Abstract][Full Text] [Related]
16. Incidental power morcellation of malignancy: a retrospective cohort study.
Graebe K; Garcia-Soto A; Aziz M; Valarezo V; Heller PB; Tchabo N; Tobias DH; Salamon C; Ramieri J; Dise C; Slomovitz BM
Gynecol Oncol; 2015 Feb; 136(2):274-7. PubMed ID: 25740603
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical characteristics of unexpected uterine sarcoma after hysterectomy and myomectomy for uterine fibroids: a retrospective study of 10,248 cases.
Zhao WC; Bi FF; Li D; Yang Q
Onco Targets Ther; 2015; 8():2943-8. PubMed ID: 26508879
[TBL] [Abstract][Full Text] [Related]
18. Characterization and Preoperative Risk Analysis of Leiomyosarcomas at a High-Volume Tertiary Care Center.
Peters A; Sadecky AM; Winger DG; Guido RS; Lee TTM; Mansuria SM; Donnellan NM
Int J Gynecol Cancer; 2017 Jul; 27(6):1183-1190. PubMed ID: 28463949
[TBL] [Abstract][Full Text] [Related]
19. Fibroid morcellation: a shared clinical decision tool for mode of hysterectomy.
Hur HC; King LP; Klebanoff MJ; Hur C; Ricciotti HA
Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():122-127. PubMed ID: 26520875
[TBL] [Abstract][Full Text] [Related]
20. [Hysterectomies performed for presumed leiomyomas: should the fear of leiomyosarcoma make us apprehend non laparotomic surgical routes?].
Leung F; Terzibachian JJ; Gay C; Chung Fat B; Aouar Z; Lassabe C; Maillet R; Riethmuller D
Gynecol Obstet Fertil; 2009 Feb; 37(2):109-14. PubMed ID: 19200764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]